Source: Outcomes4Me From: prnewswire.com Update includes new treatments, pembrolizumab and olaparib, for early-stage breast cancer today announced it has updated its mobile app to include the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Breast Cancer V.6.2021 released last week. The app serves as a digital health partner that proactively delivers timely information of value to empower patients to …
-
-
Regrets After a Cancer Diagnosis
-
You Are Not Alone After a Breast Cancer Diagnosis
-
The Past and Future Collide After a Breast Cancer Diagnosis
-
Focusing on the Positive After a Breast Cancer Diagnosis
-
My Message of Easter for the Breast Cancer Community
